Aandeel Schott Pharma | Filter Basic-Info
Aandeel: Schott Pharma (Duitsland small caps)
| Koers | 21.40 | Hoogste koers | 25.50 |
| Laagste koers | 4.97 | 1-jrs rend. | -25.63 |
| Gem. Koersd. | 19.33 | Ver. Rend. | -11.52 % |
| Sector | Gezondheid | Subsector | Farmaceuten |
| Verkopen | 0 | Rating |
|
| Houden | 1 | Consensus |
 
|
| Kopen | 2 |
Loading...
Contactinformatie:Land: Duitsland
Sectorvergelijking Schott Pharma
Loading...
| Jaar | Omzet | Totaal omzet sector | Marktaandeel |
|---|---|---|---|
| 2019 | 0 | 474,848 | 0.00 % |
| 2020 | 584 | 469,560 | 0.12 % |
| 2021 | 649 | 566,739 | 0.11 % |
| 2022 | 821 | 640,095 | 0.13 % |
| 2023 | 899 | 590,728 | 0.15 % |
Adviezen Schott Pharma
| Date Label | Bank Label | Stock Label | Advice Label | Price Label | Diff Label |
|---|---|---|---|---|---|
| 12 augustus 2026 | RBC Capital Markets | Schott Pharma | Kopen | 21.00 | -4.05 % |
| 6 juli 2026 | Deutsche Bank | Schott Pharma | Kopen | 22.00 | 0.68 % |
| 8 december 2025 | Barclays | Schott Pharma | Houden | 15.00 | -45.67 % |
| 17 mei 2026 | Deutsche Bank | Schott Pharma | Houden | 16.00 | -36.56 % |
| 3 november 2025 | DZ Bank | Schott Pharma | Kopen | 24.00 | -4.17 % |
| 12 augustus 2025 | Jefferies & Co. | Schott Pharma | Houden | 24.30 | 8.23 % |
| 28 november 2024 | UBS | Schott Pharma | Houden | 32.60 | 42.02 % |
| 28 november 2024 | Barclays | Schott Pharma | Kopen | 27.00 | 30.00 % |
| 2 september 2024 | Jefferies & Co. | Schott Pharma | Houden | 31.80 | 28.62 % |
| 1 september 2024 | UBS | Schott Pharma | Houden | 32.60 | 27.91 % |
| 9 juli 2024 | UBS | Schott Pharma | Kopen | 32.60 | 12.58 % |
| 9 juli 2024 | Berenberg | Schott Pharma | Kopen | 32.00 | 10.94 % |
| 9 juli 2024 | Barclays | Schott Pharma | Kopen | 30.00 | 5.00 % |
| 4 juli 2024 | Jefferies & Co. | Schott Pharma | Houden | 32.70 | 12.84 % |
Nieuws Schott Pharma
No Records Found
Rapporten Schott Pharma
No Records Found
Profiel Schott Pharma
No Records Found
Resultaten Schott Pharma
| Resultaten |
2021
|
2022
|
2023
|
2024
|
2025
|
|---|---|---|---|---|---|
| Omzet |
|
|
|
|
|
| Kosten |
|
|
|
|
|
| Nettowinst |
|
|
|
|
|
| Winstmarge |
|
|
|
|
|
| ROI |
|
|
|
|
|
Balans Schott Pharma
| Balans |
2021
|
2022
|
2023
|
2024
|
2025
|
|---|---|---|---|---|---|
| Eigen vermogen |
|
|
|
|
|
| Vreemd vermogen |
|
|
|
|
|
| Totaal vermogen |
|
|
|
|
|
| Solvabiliteit |
|
|
|
|
|
| Cash |
|
|
|
|
|
| Kasstroom |
|
|
|
|
|
| Werknemers |
|
|
|
|
|
| Omzet per werknemer |
|
|
|
|
|
| Kasstroom / vreemd vermogen |
|
|
|
|
|
Details Schott Pharma
| Details |
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|
| Koers |
0.0
|
0.0
|
0.0
|
0.0
|
21.85
|
| Winst per aandeel |
0.0
|
0.0
|
0.0
|
0.0
|
0.51
|
| Koers / winst-verhouding |
0.0
|
0.0
|
0.0
|
0.0
|
42.84
|
| Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
| Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Boekwaarde |
0.0
|
0.0
|
0.0
|
0.0
|
2.09
|
| Boek / koers |
0.0
|
0.0
|
0.0
|
0.0
|
0.10
|
| Kasstroom per aandeel |
0.0
|
0.0
|
0.0
|
0.0
|
0.69
|
| Aandelen |
0
|
0
|
0
|
0
|
151
|
| Marktkap. |
0,00
|
0,00
|
0,00
|
0,00
|
3.290,94
|
Dividend Schott Pharma
Koersinfo Schott Pharma
|
Datum
|
Koers
|
|---|---|
|
10 nov 2026
|
21.25
|
|
06 nov 2026
|
21.85
|
|
05 nov 2026
|
23.35
|
|
04 nov 2026
|
24.00
|
|
03 nov 2026
|
25.05
|
|
02 nov 2026
|
25.00
|
|
30 okt 2026
|
25.30
|
|
29 okt 2026
|
25.25
|
|
28 okt 2026
|
25.50
|
|
27 okt 2026
|
25.50
|
|
13 okt 2026
|
24.10
|
|
09 okt 2026
|
24.65
|
|
08 okt 2026
|
25.15
|
|
06 okt 2026
|
24.70
|
|
17 sep 2026
|
23.05
|
|
15 sep 2026
|
22.60
|
|
14 sep 2026
|
23.05
|
|
28 aug 2026
|
23.45
|
|
11 aug 2026
|
22.30
|
|
07 aug 2026
|
21.90
|
|
06 aug 2026
|
22.15
|
|
28 jul 2026
|
20.85
|
|
14 jul 2026
|
20.75
|
|
10 jul 2026
|
20.00
|
|
30 jun 2026
|
17.16
|
|
23 mei 2026
|
7.15
|
|
01 mei 2026
|
7.54
|
|
28 apr 2026
|
7.15
|
|
21 apr 2026
|
6.04
|
|
14 apr 2026
|
6.00
|
| Over ons | Netwerk | Partners | Social |
| Over AnalistMethodeDisclaimerAdverterenPersContactRSS feedinfo@analist.nl | Analist.nlLinksISINGlossary | vwd GroupEuronextPrudena.comAAII.comNASDAQBATS Chi-x |
 
|
©2026 Analist. Alle rechten voorbehouden
Developed and maintained by 